Europe • Frankfurt Stock Exchange • FRA:RDC • NL0012044747
The current stock price of RDC.DE is 61.675 EUR. In the past month the price decreased by -8.22%. In the past year, price decreased by -50.82%.
ChartMill assigns a fundamental rating of 3 / 10 to RDC.DE. While RDC.DE seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months RDC.DE reported a non-GAAP Earnings per Share(EPS) of -1.75. The EPS decreased by -39.61% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -2.88% | ||
| ROE | -7.01% | ||
| Debt/Equity | 0.62 |
16 analysts have analysed RDC.DE and the average price target is 138.07 EUR. This implies a price increase of 123.87% is expected in the next year compared to the current price of 61.675.
For the next year, analysts expect an EPS growth of 48.65% and a revenue growth 25.07% for RDC.DE
Redcare Pharmacy NV engages in the business of prescription and non-prescription pharmaceuticals; beauty and personal care (BPC) products; and food supplements. The company is headquartered in Sevenum, Limburg and currently employs 2,659 full-time employees. The company went IPO on 2016-10-13. The firm focuses on non-prescription medication (OTC), as well as on pharmacy-related beauty and personal care (BPC) products. The firm is active in Belgium, Spain, Italy, France, Austria, the Netherlands and Germany.
REDCARE PHARMACY NV
Erik de Rodeweg 11/13
Sevenum LIMBURG NL
Employees: 1827
Redcare Pharmacy NV engages in the business of prescription and non-prescription pharmaceuticals; beauty and personal care (BPC) products; and food supplements. The company is headquartered in Sevenum, Limburg and currently employs 2,659 full-time employees. The company went IPO on 2016-10-13. The firm focuses on non-prescription medication (OTC), as well as on pharmacy-related beauty and personal care (BPC) products. The firm is active in Belgium, Spain, Italy, France, Austria, the Netherlands and Germany.
The current stock price of RDC.DE is 61.675 EUR. The price increased by 3.22% in the last trading session.
RDC.DE does not pay a dividend.
RDC.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
16 analysts have analysed RDC.DE and the average price target is 138.07 EUR. This implies a price increase of 123.87% is expected in the next year compared to the current price of 61.675.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on RDC.DE.
REDCARE PHARMACY NV (RDC.DE) has a market capitalization of 1.27B EUR. This makes RDC.DE a Small Cap stock.